Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP977827.RAHkEv4Ihekeq9EyhEjLoyvs3iRKzdEa_77MH7iFrirN8130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP977827.RAHkEv4Ihekeq9EyhEjLoyvs3iRKzdEa_77MH7iFrirN8130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP977827.RAHkEv4Ihekeq9EyhEjLoyvs3iRKzdEa_77MH7iFrirN8130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP977827.RAHkEv4Ihekeq9EyhEjLoyvs3iRKzdEa_77MH7iFrirN8130_provenance.
- NP977827.RAHkEv4Ihekeq9EyhEjLoyvs3iRKzdEa_77MH7iFrirN8130_assertion description "[In addition, geldanamycin (HSP90 inhibitor) and two CHK1 inhibitors (UCN-01 and SB218078) exhibited a significantly stronger synergism with cisplatin in FA-proficient cells when compared to FA-deficient cells, suggesting a contribution of their FA pathway inhibitory activity to cisplatin sensitization.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP977827.RAHkEv4Ihekeq9EyhEjLoyvs3iRKzdEa_77MH7iFrirN8130_provenance.
- NP977827.RAHkEv4Ihekeq9EyhEjLoyvs3iRKzdEa_77MH7iFrirN8130_assertion evidence source_evidence_literature NP977827.RAHkEv4Ihekeq9EyhEjLoyvs3iRKzdEa_77MH7iFrirN8130_provenance.
- NP977827.RAHkEv4Ihekeq9EyhEjLoyvs3iRKzdEa_77MH7iFrirN8130_assertion SIO_000772 22537224 NP977827.RAHkEv4Ihekeq9EyhEjLoyvs3iRKzdEa_77MH7iFrirN8130_provenance.
- NP977827.RAHkEv4Ihekeq9EyhEjLoyvs3iRKzdEa_77MH7iFrirN8130_assertion wasDerivedFrom befree-2016 NP977827.RAHkEv4Ihekeq9EyhEjLoyvs3iRKzdEa_77MH7iFrirN8130_provenance.
- NP977827.RAHkEv4Ihekeq9EyhEjLoyvs3iRKzdEa_77MH7iFrirN8130_assertion wasGeneratedBy ECO_0000203 NP977827.RAHkEv4Ihekeq9EyhEjLoyvs3iRKzdEa_77MH7iFrirN8130_provenance.
- befree-2016 importedOn "2016-02-19" NP977827.RAHkEv4Ihekeq9EyhEjLoyvs3iRKzdEa_77MH7iFrirN8130_provenance.